Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sha Cao

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Bioorganic & Medicinal Chemistry Letters|August 9, 2016
Discovery and structure-activity relationships of a novel isothiazolone class of bacterial type II topoisomerase inhibitorsIan R Cooper, Andrew J McCarroll, David McGarry, et al.
Ebiomedicine|November 5, 2021
Antibacterial activity of apramycin at acidic pH warrants wide therapeutic window in the treatment of complicated urinary tract infections and acute pyelonephritisKatja Becker, Sha Cao, Anna Nilsson, et al.
Gastroenterology|December 23, 2025
Depletion of Fibrinogen Suppresses Growth of Primary Tumors and Metastasis of Pancreatic Ductal AdenocarcinomaNayela N Chowdhury, Dana K Mitchell, Kadri Kangro, et al.
The Journal of Clinical Investigation|March 15, 2022
Genetically programmed alternative splicing of NEMO mediates an autoinflammatory disease phenotypeYounglang Lee, Alex W Wessel, Jiazhi Xu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 8, 2024
Association of amyloid and cardiovascular risk with cognition: Findings from KBASESoumilee Chaudhuri, Desarae A Dempsey, Yen-Ning Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2024
Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteriaDouglas L Huseby, Sha Cao, Edouard Zamaratski, et al.
Journal of Medicinal Chemistry|January 12, 2023
Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold-Based DNA Gyrase Inhibitors with Potent Activity against <i>Acinetobacter baumannii</i> and <i>Pseudomonas aeruginosa</i>Andrej Emanuel Cotman, Martina Durcik, Davide Benedetto Tiz, et al.
Journal of Medicinal Chemistry|March 6, 2023
New Dual Inhibitors of Bacterial Topoisomerases with Broad-Spectrum Antibacterial Activity and In Vivo Efficacy against Vancomycin-Intermediate <i>Staphylococcus aureus</i>Martina Durcik, Andrej Emanuel Cotman, Žan Toplak, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK pathwayMotoyuki Tsuda, Dove Keith, Colin J Daniel, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Bioorganic & Medicinal Chemistry Letters|August 9, 2016
Discovery and structure-activity relationships of a novel isothiazolone class of bacterial type II topoisomerase inhibitorsIan R Cooper, Andrew J McCarroll, David McGarry, et al.
Ebiomedicine|November 5, 2021
Antibacterial activity of apramycin at acidic pH warrants wide therapeutic window in the treatment of complicated urinary tract infections and acute pyelonephritisKatja Becker, Sha Cao, Anna Nilsson, et al.
Gastroenterology|December 23, 2025
Depletion of Fibrinogen Suppresses Growth of Primary Tumors and Metastasis of Pancreatic Ductal AdenocarcinomaNayela N Chowdhury, Dana K Mitchell, Kadri Kangro, et al.
The Journal of Clinical Investigation|March 15, 2022
Genetically programmed alternative splicing of NEMO mediates an autoinflammatory disease phenotypeYounglang Lee, Alex W Wessel, Jiazhi Xu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 8, 2024
Association of amyloid and cardiovascular risk with cognition: Findings from KBASESoumilee Chaudhuri, Desarae A Dempsey, Yen-Ning Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2024
Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteriaDouglas L Huseby, Sha Cao, Edouard Zamaratski, et al.
Journal of Medicinal Chemistry|January 12, 2023
Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold-Based DNA Gyrase Inhibitors with Potent Activity against <i>Acinetobacter baumannii</i> and <i>Pseudomonas aeruginosa</i>Andrej Emanuel Cotman, Martina Durcik, Davide Benedetto Tiz, et al.
Journal of Medicinal Chemistry|March 6, 2023
New Dual Inhibitors of Bacterial Topoisomerases with Broad-Spectrum Antibacterial Activity and In Vivo Efficacy against Vancomycin-Intermediate <i>Staphylococcus aureus</i>Martina Durcik, Andrej Emanuel Cotman, Žan Toplak, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK pathwayMotoyuki Tsuda, Dove Keith, Colin J Daniel, et al.
Pageof 14